Spots Global Cancer Trial Database for stage iiib rectal cancer

Every month we try and update this database with for stage iiib rectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer	NCT00686166	Colorectal Canc...	cetuximab capecitabine oxaliplatin therapeutic sur... radiation thera...	18 Years -	SWOG Cancer Research Network
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer	NCT01871571	Mucinous Adenoc... Signet Ring Ade... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect...	bevacizumab oxaliplatin leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Southern California
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery	NCT01515787	Colorectal Canc...	FOLFOX (chemoth... 5 FUCMT (chemor... surgery magnetic resona...	18 Years -	Alliance for Clinical Trials in Oncology
A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer	NCT00060411	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	erlotinib hydro... fluorouracil leucovorin calc... oxaliplatin bevacizumab	18 Years -	National Cancer Institute (NCI)
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking	NCT01535040	Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis...	memantine hydro... placebo	18 Years -	Wake Forest University Health Sciences
Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer	NCT01741636	Stage I Colon C... Stage I Rectal ... Stage IA Non-sm... Stage IB Non-sm... Stage IIA Colon... Stage IIA Non-s... Stage IIA Recta... Stage IIB Colon... Stage IIB Non-s... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect...	educational int... questionnaire a... quality-of-life...	21 Years -	City of Hope Medical Center
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer	NCT00005036	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	irinotecan hydr... oxaliplatin leucovorin calc... fluorouracil quality-of-life...	18 Years -	National Cancer Institute (NCI)
Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer	NCT01741636	Stage I Colon C... Stage I Rectal ... Stage IA Non-sm... Stage IB Non-sm... Stage IIA Colon... Stage IIA Non-s... Stage IIA Recta... Stage IIB Colon... Stage IIB Non-s... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect...	educational int... questionnaire a... quality-of-life...	21 Years -	City of Hope Medical Center
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer	NCT00005036	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	irinotecan hydr... oxaliplatin leucovorin calc... fluorouracil quality-of-life...	18 Years -	National Cancer Institute (NCI)
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer	NCT00686166	Colorectal Canc...	cetuximab capecitabine oxaliplatin therapeutic sur... radiation thera...	18 Years -	SWOG Cancer Research Network
SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer	NCT00103311	Recurrent Colon... Recurrent Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	ispinesib laboratory biom...	18 Years -	National Cancer Institute (NCI)
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer	NCT04044430	Metastatic Colo... Metastatic Colo... Metastatic Micr... Metastatic Rect... Stage III Colon... Stage III Color... Stage III Recta... Stage IIIA Colo... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Colo... Stage IIIC Rect... Stage IV Colon ... Stage IV Colore... Stage IV Rectal... Stage IVA Colon... Stage IVA Color... Stage IVA Recta... Stage IVB Colon... Stage IVB Color... Stage IVB Recta... Stage IVC Colon... Stage IVC Color... Stage IVC Recta...	Binimetinib Encorafenib Nivolumab Questionnaire A...	18 Years -	University of California, San Francisco
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride	NCT01416688	Colorectal Canc... Dermatologic Co... Lung Cancer Therapy-related...	assessment of t... psychosocial as... quality-of-life...	18 Years - 120 Years	SWOG Cancer Research Network
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer	NCT01807117	Recurrent Colon... Recurrent Recta... Stage IIA Colon... Stage IIA Recta... Stage IIB Colon... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	positron emissi... computed tomogr... magnetic resona... fludeoxyglucose...	22 Years -	Case Comprehensive Cancer Center
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors	NCT01131234	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Solid Neo... Male Breast Car... Recurrent Adult... Recurrent Breas... Recurrent Colon... Recurrent Melan... Recurrent Non-S... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Stage III Pancr... Stage III Renal... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Skin... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Skin... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Skin... Stage IV Breast... Stage IV Non-Sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Skin M... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Gamma-Secretase... Cediranib Malea... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer	NCT01212887	Breast Cancer Colorectal Canc... Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... Unspecified Adu...	MFE23 scFv-expr... aldesleukin cyclophosphamid... fludarabine pho... laboratory biom... pharmacological...	18 Years -	Cancer Research UK
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer	NCT02575508	Colon Adenocarc... Metastatic Panc... Pancreatic Aden... Pancreatic Duct... Rectal Adenocar... Stage III Pancr... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IV Pancre... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Fluorouracil Irinotecan Hydr... Laboratory Biom... Oxaliplatin pan FGFR Kinase... Pharmacological...	18 Years -	Roswell Park Cancer Institute
Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment	NCT02287727	Rectal Adenocar... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage IIIA Rect... Stage IIIB Rect...	Laboratory Biom... Regorafenib	18 Years -	Roswell Park Cancer Institute
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma	NCT00754494	Adenomatous Pol... Recurrent Colon... Recurrent Recta... Stage I Colon C... Stage I Rectal ... Stage IIA Colon... Stage IIA Recta... Stage IIB Colon... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect...	erlotinib hydro... placebo laboratory biom...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery	NCT01263171	Colorectal Canc...	Leucovorin fluorouracil leucovorin calc... oxaliplatin adjuvant therap... neoadjuvant the... therapeutic con... radiation thera...	18 Years - 120 Years	Cardiff University
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking	NCT01535040	Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis...	memantine hydro... placebo	18 Years -	Wake Forest University Health Sciences
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery	NCT02232152	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	6,8-bis(benzylt... fluorouracil pharmacological... laboratory biom...	18 Years -	Wake Forest University Health Sciences
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation	NCT02132858	Mucinous Adenoc... Recurrent Recta... Signet Ring Ade... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect...	cytology specim... laboratory biom...	18 Years -	Fox Chase Cancer Center
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer	NCT01871571	Mucinous Adenoc... Signet Ring Ade... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect...	bevacizumab oxaliplatin leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Southern California
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer	NCT00003799	Adenocarcinoma ... Mucinous Adenoc... Signet Ring Ade... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect...	fluorouracil oxaliplatin radiation thera... leucovorin calc... therapeutic con...	18 Years -	National Cancer Institute (NCI)
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer	NCT02270606	Mucinous Adenoc... Recurrent Recta... Signet Ring Ade... Rectal Adenocar... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect...	intensity-modul... fluorouracil oxaliplatin leucovorin calc... therapeutic con...	18 Years -	Virginia Commonwealth University
SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer	NCT00103311	Recurrent Colon... Recurrent Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	ispinesib laboratory biom...	18 Years -	National Cancer Institute (NCI)
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking	NCT01535040	Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis...	memantine hydro... placebo	18 Years -	Wake Forest University Health Sciences
Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery	NCT01802320	Colon Mucinous ... Colon Signet Ri... Rectal Mucinous... Rectal Signet R... Recurrent Colon... Recurrent Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Akt Inhibitor M... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery	NCT01263171	Colorectal Canc...	Leucovorin fluorouracil leucovorin calc... oxaliplatin adjuvant therap... neoadjuvant the... therapeutic con... radiation thera...	18 Years - 120 Years	Cardiff University
Programs to Support You During Chemotherapy (Pro-You)	NCT02148406	Depressive Symp... Fatigue Psychosocial Ef... Stage IIA Colon... Stage IIA Recta... Stage IIB Colon... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Yoga Skills Tra... questionnaire a... fatigue and dep... psychological s... laboratory biom... Attention Contr...	18 Years -	Vanderbilt-Ingram Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: